Title:
HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2
Document Type and Number:
WIPO Patent Application WO/2020/022323
Kind Code:
A1
Abstract:
A compound of formula (I):wherein Ring A, Q, R1,R2, R3, R4, R5, R6, R7, R8, R9, R10, R11,X, a,b, c and d are as defined in the specification.
Inventors:
SHIMAMURA TADASHI (JP)
KATO RYO (JP)
MIURA RISAKO (JP)
MITA TAKASHI (JP)
OGAWA TAKAHIRO (JP)
SAGARA YUFU (JP)
JOHNSON CHRISTOPHER NORBERT (GB)
HOWARD STEVEN (GB)
DAY JAMES EDWARD HARVEY (GB)
ST DENIS JEFFREY DAVID (GB)
LIEBESCHUETZ JOHN WALTER (GB)
KATO RYO (JP)
MIURA RISAKO (JP)
MITA TAKASHI (JP)
OGAWA TAKAHIRO (JP)
SAGARA YUFU (JP)
JOHNSON CHRISTOPHER NORBERT (GB)
HOWARD STEVEN (GB)
DAY JAMES EDWARD HARVEY (GB)
ST DENIS JEFFREY DAVID (GB)
LIEBESCHUETZ JOHN WALTER (GB)
Application Number:
PCT/JP2019/028822
Publication Date:
January 30, 2020
Filing Date:
July 23, 2019
Export Citation:
Assignee:
TAIHO PHARMACEUTICAL CO LTD (JP)
OTSUKA PHARMA CO LTD (JP)
OTSUKA PHARMA CO LTD (JP)
International Classes:
C07D519/00; A61K31/519; A61P35/00; A61P43/00; C07D451/02; C07D487/04
Domestic Patent References:
| WO2016203404A1 | 2016-12-22 | |||
| WO2018130928A1 | 2018-07-19 | |||
| WO2017156397A1 | 2017-09-14 | |||
| WO2019165073A1 | 2019-08-29 | |||
| WO2019118909A1 | 2019-06-20 |
Other References:
See also references of EP 3827009A4
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: